Last updated on February 2019

MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034)

Brief description of study

This study aims to evaluate the safety and tolerability of MK-7625A (ceftolozane/tazobactam) compared with that of meropenem in pediatric participants with cUTI, including pyelonephritis.

Clinical Study Identifier: NCT03230838

Contact Investigators or Research Sites near you

Start Over

Study Coordinator

SPZOZ im. Dzieci Warszawy w Dziekanowie Lesnym ( Site 1608)
Lomianki, Poland
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.